105 related articles for article (PubMed ID: 28899583)
1. What could be learned from a decade with standardized remission criteria in schizophrenia spectrum disorders: An exploratory follow-up study.
Johansson M; Hjärthag F; Helldin L
Schizophr Res; 2018 May; 195():103-109. PubMed ID: 28899583
[TBL] [Abstract][Full Text] [Related]
2. [Symptomatic remission and its relationship to social functioning in Tunisian out-patients with schizophrenia].
El Gharbi I; Chhoumi M; Mechri A
Encephale; 2019 Feb; 45(1):15-21. PubMed ID: 29195805
[TBL] [Abstract][Full Text] [Related]
3. Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.
Chang WC; Ming Hui CL; Yan Wong GH; Wa Chan SK; Ming Lee EH; Hai Chen EY
J Clin Psychiatry; 2013 Nov; 74(11):e1046-53. PubMed ID: 24330905
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of functional remission in schizophrenic disorder. The FROGS Scale].
Rouillon F; Baylé FJ; Gorwood P; Lancrenon S; Lançon C; Llorca PM;
Encephale; 2013 May; 39 Suppl 1():S15-21. PubMed ID: 23541143
[TBL] [Abstract][Full Text] [Related]
5. The importance of cross-sectional remission in schizophrenia for long-term outcome: a clinical prospective study.
Helldin L; Kane JM; Hjärthag F; Norlander T
Schizophr Res; 2009 Nov; 115(1):67-73. PubMed ID: 19666215
[TBL] [Abstract][Full Text] [Related]
6. Remission after first-episode schizophrenia: results of a long-term follow-up.
Üçok A; Serbest S; Kandemir PE
Psychiatry Res; 2011 Aug; 189(1):33-7. PubMed ID: 21196051
[TBL] [Abstract][Full Text] [Related]
7. One-year functional outcomes of naturalistically treated patients with schizophrenia.
Spellmann I; Riedel M; Schennach R; Seemüller F; Obermeier M; Musil R; Jäger M; Schmauß M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Möller HJ
Psychiatry Res; 2012 Aug; 198(3):378-85. PubMed ID: 22421065
[TBL] [Abstract][Full Text] [Related]
8. The concurrent and predictive validity of symptomatic remission criteria in first-episode schizophrenia.
Chang WC; Chan TC; Chen ES; Hui CL; Wong GH; Chan SK; Lee EH; Chen EY
Schizophr Res; 2013 Jan; 143(1):107-15. PubMed ID: 23151398
[TBL] [Abstract][Full Text] [Related]
9. Achieving symptomatic remission in out-patients with schizophrenia--a naturalistic study with quetiapine.
Wobrock T; Köhler J; Klein P; Falkai P
Acta Psychiatr Scand; 2009 Aug; 120(2):120-8. PubMed ID: 19392812
[TBL] [Abstract][Full Text] [Related]
10. Remission in schizophrenia: a community-based 6-year follow-up study in Bali.
Kurihara T; Kato M; Reverger R; Tirta IG
Psychiatry Clin Neurosci; 2011 Aug; 65(5):476-82. PubMed ID: 21851456
[TBL] [Abstract][Full Text] [Related]
11. A prospective, open-label study to evaluate symptomatic remission in schizophrenia with risperidone long-acting injectable in Korea.
Lee NY; Kim SH; Cho SJ; Chung YC; Jung IK; Kim CY; Kim DH; Lee DG; Lee YH; Lim WJ; Na YS; Shin SE; Woo JM; Yoon JS; Yoon BH; Ahn YM; Kim YS
Int Clin Psychopharmacol; 2014 Sep; 29(5):279-87. PubMed ID: 24583566
[TBL] [Abstract][Full Text] [Related]
12. The "Functional Remission of General Schizophrenia" (FROGS) scale: development and validation of a new questionnaire.
Llorca PM; Lançon C; Lancrenon S; Bayle FJ; Caci H; Rouillon F; Gorwood P
Schizophr Res; 2009 Sep; 113(2-3):218-25. PubMed ID: 19464855
[TBL] [Abstract][Full Text] [Related]
13. Predictors of symptomatic remission in patients with first-episode schizophrenia: a 16years follow-up study.
Marchesi C; Affaticati A; Monici A; De Panfilis C; Ossola P; Tonna M
Compr Psychiatry; 2014 May; 55(4):778-84. PubMed ID: 24461689
[TBL] [Abstract][Full Text] [Related]
14. Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders.
Schennach-Wolff R; Jäger M; Seemüller F; Obermeier M; Messer T; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Huff W; Heuser I; Maier W; Lemke MR; Rüther E; Buchkremer G; Gastpar M; Möller HJ; Riedel M
Schizophr Res; 2009 Sep; 113(2-3):210-7. PubMed ID: 19560901
[TBL] [Abstract][Full Text] [Related]
15. Relationship of symptomatic remission with quality of life and functionality in patients with schizophrenia.
Karadayi G; Emiroğlu B; Uçok A
Compr Psychiatry; 2011; 52(6):701-7. PubMed ID: 21296345
[TBL] [Abstract][Full Text] [Related]
16. An early improvement in depressive symptoms predicts symptomatic remission of schizophrenia treated with quetiapine: a multicenter, 4-week case-control study.
Chou YH; Chiu NM; Yang TT; Feng J; Chan CC; Lee HK;
Int Clin Psychopharmacol; 2013 Sep; 28(5):255-60. PubMed ID: 23820333
[TBL] [Abstract][Full Text] [Related]
17. Recovery from schizophrenia: results from a 1-year follow-up observational study of patients in symptomatic remission.
Bobes J; Ciudad A; Alvarez E; San L; Polavieja P; Gilaberte I
Schizophr Res; 2009 Nov; 115(1):58-66. PubMed ID: 19729283
[TBL] [Abstract][Full Text] [Related]
18. Extent of attaining and maintaining symptom remission by antipsychotic medication in the treatment of chronic schizophrenia: evidence from the CATIE study.
Levine SZ; Rabinowitz J; Ascher-Svanum H; Faries DE; Lawson AH
Schizophr Res; 2011 Dec; 133(1-3):42-6. PubMed ID: 22000938
[TBL] [Abstract][Full Text] [Related]
19. Symptomatic remission and neurocognitive functioning in patients with schizophrenia.
Hofer A; Bodner T; Kaufmann A; Kemmler G; Mattarei U; Pfaffenberger NM; Rettenbacher MA; Trebo E; Yalcin N; Fleischhacker WW
Psychol Med; 2011 Oct; 41(10):2131-9. PubMed ID: 21426601
[TBL] [Abstract][Full Text] [Related]
20. Remission in schizophrenia: results from a 1-year follow-up observational study.
Ciudad A; Alvarez E; Bobes J; San L; Polavieja P; Gilaberte I
Schizophr Res; 2009 Mar; 108(1-3):214-22. PubMed ID: 19168329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
